MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 17.11.2025
AIM ImmunoTech PEG 2011-2026 | AIM
PEG Jährlich AIM ImmunoTech
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00474 | 0.0101 | -0.0639 | -0.00529 | -0.041 | -0.12 | -0.0364 | -0.0419 | -0.237 | -0.272 | 0.0341 | -0.235 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.0341 | -0.272 | -0.0837 |
PEG anderer Aktien in der Pharmaeinzelhändler
| Name | PEG | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
-0.0372 | - | 1052.0 % | $ 415 M |  USA |
 |
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M |  Canada |
 |
Albireo Pharma
ALBO
|
-2.41 | - | -0.23 % | $ 916 M | USA |
 |
Aileron Therapeutics
ALRN
|
-0.00319 | - | 10.36 % | $ 9.8 M | USA |
 |
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B |  France |
 |
Ascendis Pharma A/S
ASND
|
-0.767 | $ 220.94 | 2.51 % | $ 5 B |  Danmark |
 |
Aptinyx
APTX
|
-0.0809 | - | -39.0 % | $ 4.57 M | USA |
 |
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | USA |
 |
MediWound Ltd.
MDWD
|
0.0499 | $ 17.08 | 2.83 % | $ 465 M |  Israel |
 |
Amphastar Pharmaceuticals
AMPH
|
0.154 | $ 19.7 | 2.44 % | $ 921 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | USA |
 |
Mesoblast Limited
MESO
|
1.3 | $ 15.54 | 8.48 % | $ 10.1 B |  Australia |
 |
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M | Israel |
 |
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | USA |
 |
Acorda Therapeutics
ACOR
|
-0.000047 | - | -24.86 % | $ 820 K | USA |
 |
Atreca
BCEL
|
0.187 | - | -11.76 % | $ 5.79 M | USA |
 |
Acasti Pharma
ACST
|
-0.0483 | - | 4.01 % | $ 150 M | Canada |
 |
BeiGene, Ltd.
BGNE
|
9.68 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Mirum Pharmaceuticals
MIRM
|
-0.428 | $ 90.9 | 3.44 % | $ 4.56 B | USA |
 |
bluebird bio
BLUE
|
0.0148 | - | - | $ 546 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - |  Russia |
 |
Cara Therapeutics
CARA
|
0.00142 | - | -3.03 % | $ 260 M | USA |
 |
Adverum Biotechnologies
ADVM
|
-0.00407 | - | - | $ 86.2 M | USA |
 |
Acer Therapeutics
ACER
|
0.0443 | - | 2.71 % | $ 14 M | USA |
 |
Advaxis
ADXS
|
-0.000022 | - | -9.65 % | $ 45.9 M | USA |
 |
MediciNova
MNOV
|
-3.01 | $ 1.44 | -0.68 % | $ 70.7 M | USA |
 |
Avenue Therapeutics
ATXI
|
-0 | - | -52.27 % | $ 4.45 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
0.0906 | $ 1.36 | 3.03 % | $ 347 M | Britain |
 |
CytomX Therapeutics
CTMX
|
0.413 | $ 4.41 | 3.98 % | $ 608 M | USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
-0.0018 | - | -5.98 % | $ 34.1 M | USA |
 |
ChemoCentryx
CCXI
|
-0 | - | - | $ 3.74 B | USA |
 |
Merck & Co.
MRK
|
1.18 | $ 118.9 | 2.17 % | $ 297 B | USA |
 |
Dynavax Technologies Corporation
DVAX
|
-0.688 | - | - | $ 2.02 B | USA |
 |
BioDelivery Sciences International
BDSI
|
0.69 | - | -4.8 % | $ 255 M | USA |
 |
Enochian Biosciences
ENOB
|
-0.00709 | - | - | $ 40.5 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | Germany |
 |
Bellerophon Therapeutics
BLPH
|
0.0308 | - | -74.18 % | $ 955 K | USA |
 |
Akero Therapeutics
AKRO
|
-0.964 | - | - | $ 3.67 B | USA |
 |
Neurocrine Biosciences
NBIX
|
0.957 | $ 131.82 | 3.1 % | $ 13.1 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
1.34 | $ 4.56 | 5.68 % | $ 874 M | Canada |
 |
Homology Medicines
FIXX
|
0.168 | - | 0.77 % | $ 53.4 M | USA |
 |
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | USA |
 |
AIkido Pharma
AIKI
|
-0.000777 | - | 1.93 % | $ 17.4 M | USA |
 |
Allakos
ALLK
|
0.664 | - | - | $ 28.6 M | USA |